Optimization of Individualized Therapy for CRCs With Secondary RESISTance Towards Anti-EGFR Targeted Therapy Using an Avatar Model

Clinical trial NCT03263663 · UNKNOWN

Trial details

NCT number: NCT03263663
Sponsor: PD Dr. med. Volker Heinemann
Status: UNKNOWN
Study type: OBSERVATIONAL

Colo-rectal Cancer RAS Wild-type UICC III UICC II + RF UICC IV Curative Intent

Start date: 2017-01-01
Primary completion: 2021-01-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.